MedTrace Logo

Effectiveness of Port Site Bupivacaine Injection in Postoperative Pain Reduction After Lap. Chole

NCT05264805 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 166

Last updated 2022-03-03

No results posted yet for this study

Summary

To determine the effectiveness of port site bupivacaine infiltration in postoperative pain reduction after laparoscopic cholecystectomy.

Conditions

  • Pain, Postoperative

Interventions

DRUG

0.25% Bupivacaine

20ml of 0.25% Bupivacaine subcutaneous infiltration at port site wound.

Sponsors & Collaborators

  • Hamdard University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-03-31
Primary Completion
2022-09-30
Completion
2022-09-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05264805 on ClinicalTrials.gov